drugset / Trial / NCT00769314

Phase 3 Clinical Study for the Treatment of Cold Sore

NCT00769314

Phase 3 Completed 1727 enrolled Valerio Therapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

To demonstrate the efficacy of a single dose of acyclovir Lauriad® 50mg muco-adhesive buccal tablet versus a single dose of matching placebo on the primary vesicular lesion of cold sore.

Timeline

Start
2007-05
Primary completion
2008-11
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Acyclovir Small molecule 50 mg Other

Indications